Paul R Bourdon

Title: Paul R Bourdon: Innovator in Thrombin Inhibition

Introduction

Paul R Bourdon is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of biomedical innovations, particularly in the development of thrombin inhibitors. With a total of three patents to his name, Bourdon's work has the potential to impact therapeutic and diagnostic applications.

Latest Patents

Bourdon's latest patents focus on methods for coating invasive devices with inhibitors of thrombin. This invention relates to the use of novel biologically active molecules that bind to and inhibit thrombin. The molecules include a catalytic site directed moiety (CSDM) characterized by specific structural components. Additionally, his work on inhibitors of thrombin also involves similar biologically active molecules designed for therapeutic purposes. These inventions highlight his commitment to advancing medical technology and improving patient outcomes.

Career Highlights

Bourdon is associated with Biogen, Incorporated, a leading biotechnology company. His role at Biogen has allowed him to collaborate with other experts in the field and contribute to groundbreaking research. His patents reflect a deep understanding of biochemistry and a dedication to innovation in medical devices.

Collaborations

Some of Bourdon's notable coworkers include John M Maraganore and Jo-Ann M Jablonski. Their collaborative efforts have likely enhanced the research and development processes at Biogen.

Conclusion

Paul R Bourdon's contributions to thrombin inhibition and biomedical innovations underscore his importance as an inventor in the field. His patents not only demonstrate his expertise but also hold promise for future advancements in medical technology.